Literature DB >> 20202051

Aggravating factors for melasma: a prospective study in 197 Tunisian patients.

C Guinot1, S Cheffai, J Latreille, M A Dhaoui, S Youssef, K Jaber, O Nageotte, N Doss.   

Abstract

BACKGROUND: Melasma is a frequent cause of consultations at dermatology departments by dark-skinned patients in Tunisia.
OBJECTIVE: To investigate factors that influence melasma severity in a large Tunisian population.
METHODS: A total of 197 patients (188 women and 9 men), who attended Tunis Military Hospital for a consultation were included prospectively from August 2005 to August 2006. Disease severity was estimated using the Melasma Area and Severity Index (MASI). Aggravating factors were investigated using multiple logistic regressions.
RESULTS: Of the women included, 14% presented phototype III, 45% phototype IV and 41% phototype V; 76% presented a centrofacial melasma phenotype, 23% a malar and 1% a mandibular phenotype. About 60% developed melasma before thirty. Sun exposure was reported as a triggering factor by 51% of women and as an aggravating factor by 84%. Pregnancy was reported as an aggravating factor by 51% of women who had been pregnant, and oral contraceptive use reported by 38% of women exposed to oral contraceptives. The risk of severe melasma was about three times higher for women with age at onset under 30, phototype V and major lifetime sun exposure and about 8 times higher for women exposed to oral contraceptives.
CONCLUSION: This study identifies a number of factors associated with the severity of melasma. Further epidemiological studies in this type of population, in particular, to investigate triggering factors, are justified by the aesthetic damage caused by melasma in dark-skinned patients, lack of efficacy of existing treatments, non-compliance with photoprotection recommendations and the challenge of treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20202051     DOI: 10.1111/j.1468-3083.2010.03592.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

1.  Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.

Authors:  Bhumika Chowdhary; Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan; Vikas Sharma; Anuj Sharma; Sanket Vashist; Prabal Kumar
Journal:  Arch Dermatol Res       Date:  2020-04-30       Impact factor: 3.017

2.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

Review 3.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

4.  Low-power Fractional Carbon Dioxide Laser Followed by Jessner's Peel versus Jessner's Peel Alone for the Treatment of Melasma.

Authors:  Eman Elmorsy; Nouran Aboukhadr; Maha Tayyeb; Alsayeda A A Taha
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

Review 5.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

6.  Clinical profile of 300 men with facial hypermelanosis.

Authors:  Mrinal Gupta; Vikram K Mahajan
Journal:  J Dermatol Case Rep       Date:  2017-12-01

Review 7.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

8.  Cosmetic contact sensitivity in patients with melasma: results of a pilot study.

Authors:  Neel Prabha; Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan; Mrinal Gupta
Journal:  Dermatol Res Pract       Date:  2014-07-14

9.  Is There a Correlation between Severity of Melasma and Quality of Life?

Authors:  Nelva Karmila Jusuf; Imam Budi Putra; Mahdalena Mahdalena
Journal:  Open Access Maced J Med Sci       Date:  2019-08-25

Review 10.  Melasma: an Up-to-Date Comprehensive Review.

Authors:  Oluwatobi A Ogbechie-Godec; Nada Elbuluk
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.